These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20610370)

  • 1. Intermittent posaconazole regimen to treat superficial Scytalidium dimidiatum infection.
    Dunand J; Viguie C; Paugam A
    Eur J Dermatol; 2010; 20(5):649-50. PubMed ID: 20610370
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro susceptibility of isolates of Scytalidium spp. from superficial lesions against posaconazole].
    Dunand J; Paugam A
    Pathol Biol (Paris); 2008 Jul; 56(5):268-71. PubMed ID: 18325689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful eradication of Scytalidium dimidiatum-induced ungual and cutaneous infection with voriconazole.
    Spriet I; Lambrecht C; Lagrou K; Verhamme B
    Eur J Dermatol; 2012; 22(2):197-9. PubMed ID: 22377678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses.
    Gupta A; Lambert J; Revuz J; Shear N
    Eur J Dermatol; 2001; 11(1):6-10. PubMed ID: 11174129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
    Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
    Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the new antifungals: posaconazole, micafungin, and anidulafungin.
    Scheinfeld N
    J Drugs Dermatol; 2007 Dec; 6(12):1249-51. PubMed ID: 18189069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis caused by Scytalidium dimidiatum. Report of two cases. Review of the taxonomy of the synanamorph and anamorph forms of this coelomycete.
    Lacaz CS; Pereira AD; Heins-Vaccari EM; Cucé LC; Benatti C; Nunes RS; de Melo NT; de Freitas-Leite RS; Hernández-Arriagada GL
    Rev Inst Med Trop Sao Paulo; 1999; 41(5):319-23. PubMed ID: 10602547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
    Elewski B; Pollak R; Ashton S; Rich P; Schlessinger J; Tavakkol A
    Br J Dermatol; 2012 Feb; 166(2):389-98. PubMed ID: 21967490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease.
    Wildenbeest JG; Oomen MW; Brüggemann RJ; de Boer M; Bijleveld Y; van den Berg JM; Kuijpers TW; Pajkrt D
    Pediatr Infect Dis J; 2010 Jun; 29(6):578. PubMed ID: 20508483
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of relapsing disseminated coccidioidomycosis with cutaneous involvement with posaconazole.
    Wollina U; Hansel G; Vennewald I; Schönlebe J; Tintelnot K; Seibold M; Kittner T
    J Dtsch Dermatol Ges; 2009 Jan; 7(1):46-9. PubMed ID: 18759738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dermatomycoses. 18: Topical therapy of onychomycoses, vaginal and oral mycoses].
    Meinhof W
    Fortschr Med; 1996 Jan; 114(3):21-3. PubMed ID: 8851784
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scytalidium dimidiatum pseudodermatophyte, agent of superficial mycoses and phaehyphomycosis].
    Soler CP; Gerome P; Leguyadec T; Hance P; Nizou JY; Le Vagueresse R
    Med Trop (Mars); 1999; 59(4):375-7. PubMed ID: 10816752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ungual aspergillosis successfully treated with topical efinaconazole.
    Noguchi H; Hiruma M; Matsumoto T; Kano R; Ihn H
    J Dermatol; 2017 Jul; 44(7):848-850. PubMed ID: 27511741
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of common superficial fungal infections.
    Huang DB; Ostrosky-Zeichner L; Wu JJ; Pang KR; Tyring SK
    Dermatol Ther; 2004; 17(6):517-22. PubMed ID: 15571501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in topical and systemic antifungals.
    Zhang AY; Camp WL; Elewski BE
    Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intermittent-pulse treatment of onychomycosis with orally administered itraconazole].
    Yan L; Wen H; Zhong Y; Cao C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):71-3. PubMed ID: 11938747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Borelli S; Lautenschlager S
    Ther Umsch; 2016; 73(8):457-461. PubMed ID: 27731788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Info-congress. Itraconazole in the treatment of dermatomycoses and onychomycoses. Current concept of intermittent therapy using weekly units repeated monthly].
    Piérard GE; Piérard-Franchimont C
    Rev Med Liege; 1996 Nov; 51(11):729-30. PubMed ID: 9011929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dermatomycoses. 4: Onychomycoses--therapy--pathogens].
    Meinhof W
    Fortschr Med; 1995 Jul; 113(19):301-2. PubMed ID: 7672746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.